Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge? episode artwork

EPISODE · Jun 25, 2025 · 35 MIN

Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?

from PharmaTalkRadio · host Conference Forum

Summary:The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can bring new researchers and new sites into clinical research, and lead to reduced risk to sponsors, increased predictability, streamlined site operations and greater access for patients. More specifically, this panel focuses on: What is the true value of site networks?What does the landscape look like today – by TA/country / region?If scaled, what will the benefit look like for patients and can it impact the speed of treatment to patients?Case examples of the impact of current clinical research networksIn this panel:Mark Travers, PhD, MBA, VP, Head of GCTO Regions, Monitoring Excellence, Global Operations and eTMF, MerckPaul Evans, President and CEO, Velocity Clinical ResearchMark Scullion, MBA, CEO, Atlas Clinical ResearchNick Slack, MBE, Chairman and CEO, The START Center for Cancer ResearchFor more information, go to DPHARMconference.com. 

Summary:The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can bring new researchers and new sites into clinical research, and lead to reduced risk to sponsors, increased predictability, streamlined site operations and greater access for patients. More specifically, this panel focuses on: What is the true value of site networks?What does the landscape look like today – by TA/country / region?If scaled, what will the benefit look like for patients and can it impact the speed of treatment to patients?Case examples of the impact of current clinical research networksIn this panel:Mark Travers, PhD, MBA, VP, Head of GCTO Regions, Monitoring Excellence, Global Operations and eTMF, MerckPaul Evans, President and CEO, Velocity Clinical ResearchMark Scullion, MBA, CEO, Atlas Clinical ResearchNick Slack, MBE, Chairman and CEO, The START Center for Cancer ResearchFor more information, go to DPHARMconference.com.

NOW PLAYING

Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?

0:00 35:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 35 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on June 25, 2025.

What is this episode about?

Summary:The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this PharmaTalkRadio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!